Summit Partners Public Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-42,214
| Closed | -$6.73M | – | 87 |
|
2022
Q4 | $6.73M | Sell |
42,214
-87,826
| -68% | -$14M | 0.43% | 52 |
|
2022
Q3 | $17.3M | Buy |
130,040
+13,524
| +12% | +$1.8M | 0.89% | 27 |
|
2022
Q2 | $18.2M | Buy |
+116,516
| New | +$18.2M | 0.82% | 28 |
|
2018
Q4 | – | Sell |
-139,893
| Closed | -$23.5M | – | 62 |
|
2018
Q3 | $23.5M | Buy |
139,893
+49,893
| +55% | +$8.39M | 1.59% | 15 |
|
2018
Q2 | $15.5M | Sell |
90,000
-20,000
| -18% | -$3.45M | 1.72% | 13 |
|
2018
Q1 | $16.6M | Buy |
+110,000
| New | +$16.6M | 2.35% | 13 |
|
2017
Q3 | – | Sell |
-65,000
| Closed | -$10.1M | – | 70 |
|
2017
Q2 | $10.1M | Buy |
+65,000
| New | +$10.1M | 1.38% | 20 |
|